1-2 of 2
Emiko Ushijima
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Promising Therapeutic Implication of a Novel Bcl-2 Family Inhibitor ABT-737 for Adult T-Cell Leukemia/Lymphoma.

Kenji Ishitsuka, M.D., Ph.D., Fusanori Yotsumoto, M.D., Hiroo Katsuya, M.D., Emiko Ushijima, Shingo Miyamoto, M.D., Ph.D., Kazuo Tamura, M.D., Ph.D.
Journal: Blood
Blood (2008) 112 (11): 1584.
https://doi.org/10.1182/blood.V112.11.1584.1584
Published: 2008
Journal Articles

Am80, a RARĪ± Specific Synthetic Retinoid Induced a Strong Growth Inhibition in Hematologic Malignant Cells Including Myeloid and Lymphoid Cell Lines.

Shiro Jimi, PhD, Kota Mashima, Mitsukuni Sakabe, Emiko Ushijima, Junji Suzumiya, MD, Shuji Hara, Ph.D, Kazuo Tamura, MD
Journal: Blood
Blood (2005) 106 (11): 4438.
https://doi.org/10.1182/blood.V106.11.4438.4438
Published: 2005